SCHEMBL4769701

SCHEMBL4769701

CS(=O)(=O)N(Cc1ccc(Cl)cc1Cl)c1ccc(N(C=O)Cc2ccc(C(F)(F)F)nc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 5/20 0.36
CNR1 P21554 4/20 0.36
LMNA P02545 3/20 0.36
POLB P06746 1/20 0.36
TRPM8 Q7Z2W7 3/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
GAA P10253 1/20 0.34
NR1H2 P55055 2/20 0.34
NR1H3 Q13133 2/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4777509 0.94 CNR2 (0.37) CNR2CNR1LMNAPOLBTRPM8
SCHEMBL5571607 0.92 CNR1 (0.37) CNR2CNR1LMNATRPM8GAA
SCHEMBL4767617 0.92 TRPM8 (0.40) TRPM8GAAKDM4EMAPT
SCHEMBL5571164 0.89 GAA (0.44) CNR2CNR1LMNAPOLBTRPM8
SCHEMBL4775075 0.88 CNR2 (0.37) CNR2CNR1LMNAPOLBTRPM8
SCHEMBL4775014 0.87 TRPM8 (0.38) LMNATRPM8MEN1KMT2AGAA
SCHEMBL5571422 0.87 LMNA (0.40) CNR2CNR1LMNAPOLBTRPM8
SCHEMBL4770824 0.86 CNR1 (0.35) CNR2CNR1LMNAPOLBTRPM8
SCHEMBL4772347 0.85 GAA (0.37) CNR2CNR1LMNAPOLBTRPM8
SCHEMBL4772420 0.85 GAA (0.37) LMNAPOLBTRPM8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP disclosed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 CNR2 4377/4885CNR1 4121/4885LMNA 1022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.